ARTICLE | Distillery Therapeutics
Autoimmune disease
May 15, 2018 6:07 PM UTC
In vitro and mouse studies identified a chemokine-targeting single-chain variable fragment (scFv)-based fusion protein that could help treat arthritis. Screening of a scFv library for binding to vario...
BCIQ Company Profiles